Deniz Kural
Chief Executive Officer at Totient, Inc.
Profile
Deniz Kural is the founder of Seven Bridges Genomics, Inc., which was founded in 2009.
He held the title of Executive Chairman from 2017 to 2018.
Dr. Kural is also the founder of Totient, Inc., which was founded in 2017.
He currently holds the title of Chief Executive Officer at Totient, Inc.
Deniz Kural active positions
| Companies | Position | Start |
|---|---|---|
Totient, Inc.
 Totient, Inc. Pharmaceuticals: MajorHealth Technology Totient, Inc. provides biotechnology services. The company was founded by Deniz Kural and is headquartered in Cambridge, MA. | Chief Executive Officer | - |
Former positions of Deniz Kural
| Companies | Position | End |
|---|---|---|
Seven Bridges Genomics, Inc.
 Seven Bridges Genomics, Inc. Packaged SoftwareTechnology Services Seven Bridges Genomics, Inc. operates as a biomedical data analysis company. It offers genomics research for cancer, drug development and precision medicine. The company was founded by Deniz Kural, Igor Bogicevic and John Sheffield in 2009 and is headquartered in San Francisco, CA. | Chief Executive Officer | 2017-03-15 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Seven Bridges Genomics, Inc.
Seven Bridges Genomics, Inc. Packaged SoftwareTechnology Services Seven Bridges Genomics, Inc. operates as a biomedical data analysis company. It offers genomics research for cancer, drug development and precision medicine. The company was founded by Deniz Kural, Igor Bogicevic and John Sheffield in 2009 and is headquartered in San Francisco, CA. | Technology Services |
Totient, Inc.
Totient, Inc. Pharmaceuticals: MajorHealth Technology Totient, Inc. provides biotechnology services. The company was founded by Deniz Kural and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Deniz Kural
